[Answer] One of your subjects is half way through a study of an investigational antidepressant that is injected weekly. The drug requires a taper-down regimen that is it should NOT be stopped abruptly. You learn that the subject will be admitted to prison next week prior to the next scheduled injection. What is the appropriate response for the researcher?

Answer: The researcher should contact prison authorities of the medical issue and report the events to the IRB of record.
One of your subjects is half way through a study of an investigational antidepressant that is injected weekly. The drug requires a taper-down regimen that is it should NOT be s…

Leave a Reply